AdaptHealth Corp.
NASDAQ:AHCOMedical - Devices
+$0.01 today
- Market cap
- $1.01B
- Beta
- 1.46
- P/E (TTM)
- -16.3
- EPS (TTM)
- -$0.59
Volume 1.54M
Average 1.38M
AHCO Account Payables
Amounts the company owes suppliers for goods and services received.
AdaptHealth Corp.NASDAQ: AHCO
Account Payables · Q1 FY2026 · quarter ended Apr 2026
Account payables rises 46.8% from a year ago
Account payables stood at $431.95M at the end of Q1 FY2026, up 46.8% from a year earlier and up 22.6% from the prior quarter. Over 3 fiscal years it compounded at +16.6% a year.
Context
- Account payables amounted to 9.8% of total assets at the end of Q1 FY2026, up 3.1 pp from a year earlier.
- Account payables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +46.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 352.38M USD
- Year-over-year change
- +23.8%
- 4-year CAGR
- +9.2%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 352.38M | +23.8% |
| FY2024 | 2024-12-31 | 284.6M | +34.6% |
| FY2023 | 2023-12-31 | 211.5M | -4.9% |
| FY2022 | 2022-12-31 | 222.51M | -10.3% |
| FY2021 | 2021-12-31 | 248.03M | — |
Account Payables vs competitors
How AHCO compares with its peers on the latest reported figures
- AHCO's Apr 2026 account payables of $431.95M is the highest of the 9 companies compared; the peer median is $20.25M.
- Its year-over-year change of +46.8% is the highest of 9, against a peer median of +8.5%.
- Account payables amounts to 9.8% of total assets for AHCO, versus a peer median of 4.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Apr 2026 | $431.95M | +46.8% | +16.6% | 9.8% | |
| Jun 2026 | $308.92M | +11.1% | +27.0% | 3.4% | |
| Mar 2026 | $59.86M | +0.1% | -5.5% | 5.2% | |
| Mar 2026 | $31.3M | +34.6% | +3.6% | 10.9% | |
| Jun 2026 | $27.1M | -49.0% | +10.8% | 2.9% | |
| Mar 2026 | $13.39M | +6.0% | +36.0% | 6.8% | |
| Mar 2026 | $9.63M | +15.1% | +9.1% | 9.8% | |
| Mar 2026 | $2.6M | +38.1% | +28.4% | 4.4% | |
| Mar 2026 | $2.32M | -32.9% | +126.5% | 0.8% | |
| Peer median (excluding AHCO) | $20.25M | +8.5% | +18.9% | 4.8% | |
Competitors are the stored peer set for AHCO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 149.63M | 46.27M | 77.13M | 109.75M | 106.14M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 359.9M | 359.15M | 388.91M | 408.02M | 370.9M |
| Inventory | 123.1M | 127.75M | 113.64M | 139.84M | 151.25M |
| Other Current Assets | 0 | 52.14M | 69.34M | 98.18M | 0 |
| Total Current Assets | 670.06M | 585.31M | 649.02M | 755.79M | 728.9M |
| Property, Plant & Equipment (Net) | 546.34M | 622.01M | 637.53M | 618.36M | 674.22M |
| Goodwill | 3.51B | 3.55B | 2.72B | 2.68B | 2.54B |
| Intangible Assets | 202.23M | 162.77M | 130.16M | 105.55M | 85.12M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 304.19M | 281.79M | 345.85M | 314.51M | 267.79M |
| Other Non-current Assets | 15.1M | 22.42M | 21.13M | 17.58M | 19.12M |
| Total Non-current Assets | 4.58B | 4.63B | 3.86B | 3.73B | 3.59B |
| Total Assets | 5.25B | 5.22B | 4.51B | 4.49B | 4.32B |
| Account Payables | 248.03M | 222.51M | 211.5M | 284.6M | 352.38M |
| Short-term Debt | 20M | 35M | 53.37M | 16.25M | 20.31M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 31.37M | 31.64M | 38.57M | 34.94M | 59.84M |
| Other Current Liabilities | 43.19M | 19.86M | 14.68M | 33.55M | 79.91M |
| Total Current Liabilities | 499.81M | 456.21M | 537M | 566.99M | 712.39M |
| Long-term Debt | 2.18B | 2.15B | 2.09B | 1.96B | 1.72B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 380.25M | 344M | 302.09M | 272.02M | 243.8M |
| Total Non-current Liabilities | 2.68B | 2.61B | 2.5B | 2.34B | 2.08B |
| Total Liabilities | 3.18B | 3.06B | 3.04B | 2.91B | 2.79B |
| Common Stock | 13K | 13K | 13K | 13K | 13K |
| Retained Earnings | (43.02M) | 26.3M | (652.6M) | (562.18M) | (632.97M) |
| Accumulated OCI | (2.35M) | 8.69M | 4.36M | 2.25M | 78K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 4.78M | 6.6M | 8.22M | 6.97M | 7.76M |
| Total Equity | 2.07B | 2.16B | 1.47B | 1.58B | 1.53B |
| Total Debt | 2.37B | 2.33B | 2.29B | 2.13B | 1.9B |
| Net Debt | 2.22B | 2.28B | 2.22B | 2.02B | 1.8B |
AdaptHealth Corp.
NASDAQ:AHCO
Intrinsic Alpha fair value
Locked
Current Price
$7.37
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.